Admiring how they have handled the news/result, did as they said they would by withdrawing it from sale, allowing existing patients to continue taking it for free if the want to, yes cutting staff numbers (with full entitlements) would be an expected out for a company with no other income.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1112
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.010(4.88%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.8¢ | $342.8K | 1.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 52999 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 421000 | 3 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |